Proliferation of vascular smooth muscle cells (SMC) contributes to formation of the complicated human atherosclerotic plaque. These lesions also contain macrophages, known to secrete SMC mitogens, and T lymphocytes. Many of the SMC in the lesions express class II major histocompatibility antigens, an indication that activated T cells secrete immune IFN-gamma locally in the plaque. We therefore studied the effect of IFN-gamma on the proliferation of cultured SMC derived from adult human blood vessels. IFN-gamma (1,000 U/ml) reduced [3H]thymidine (TdR) incorporation into DNA by SMC stimulated with the well-defined mitogens IL 1 (from 15.3 +/- 0.7 to 6.2 +/- 0.7 dpm X 10(-3)/24 h) or platelet-derived growth factor (PDGF) (from 18.5 +/- 1.0 to 7.3 +/- 0.7 dpm X 10(-3)/24 h). Kinetic and nuclear labeling studies indicated that this effect of IFN-gamma was not due to altered thymidine transport or specific radioactivity of TdR in the cell. In longer term experiments (4-16 d) IFN-gamma prevented net DNA accumulation by SMC cultures stimulated by PDGF. IFN-gamma also delayed (from 30 to 60 min) the time to peak level of c-fos RNA in IL 1-treated SMC. It is unlikely that cytotoxicity caused these effects of IFN-gamma, as the inhibition of growth was reversible and we detected no cell death in SMC cultures exposed to this cytokine. Activation of 2'-5' oligoadenylate synthetase gene expression may mediate certain antiproliferative and antiviral effects of interferons. Both IFN-gamma and type I IFNs (IFN-alpha or IFN-beta) induced 2'-5' oligoadenylate synthetase mRNA and enzyme activity in SMC cultures, but with concentration dependence and time course that may not account for all of IFN-gamma's cytostatic effect on SMC. The accumulation of SMC in human atherosclerotic lesions is a long-term process that must involve altered balance between growth stimulatory and inhibitory factors. The cytostatic effect of IFN-gamma on human SMC demonstrated here may influence this balance during human atherogenesis, because T cells present in the complicated atherosclerotic plaque likely produce this cytokine.
S J Warner, G B Friedman, P Libby
Title and authors | Publication | Year |
---|---|---|
Co-treatment with interferon-γ and 1-methyl tryptophan ameliorates cardiac fibrosis through cardiac myofibroblasts apoptosis
JW Lee, JE Oh, KJ Rhee, BS Yoo, YW Eom, SW Park, JH Lee, JW Son, YJ Youn, MS Ahn, SG Ahn, JY Kim, SH Lee, J Yoon |
Molecular and Cellular Biochemistry | 2019 |
Palmitate induces glycosylation of cyclooxygenase-2 in primary human vascular smooth muscle cells
P Raman, L Madhavpeddi, RJ Gonzales |
American journal of physiology. Cell physiology | 2018 |
Cardiovascular Imaging
E Aikawa |
2014 | |
PETER LIBBY, MD: A Conversation With the Editor
P Libby, WC Roberts |
The American Journal of Cardiology | 2012 |
Dihydrotestosterone alters cyclooxygenase-2 levels in human coronary artery smooth muscle cells
KL Osterlund, RJ Handa, RJ Gonzales |
American journal of physiology. Endocrinology and metabolism | 2010 |
RFXB and its splice variant RFXBSV mediate the antagonism between IFN and TGF on COL1A2 transcription in vascular smooth muscle cells
M Fang, X Kong, P Li, F Fang, X Wu, H Bai, X Qi, Q Chen, Y Xu |
Nucleic Acids Research | 2009 |
Interferon Gamma Enhances Clonal Expansion and Survival of CD4+T Cells
JM Reed, PJ Branigan, A Bamezai |
Journal of Interferon & Cytokine Research | 2008 |
Antiangiogenic Agents in Cancer Therapy
BA Teicher, LM Ellis |
2008 | |
Les lymphocytes t régulateurs protègent contre le développement de l'athérosclérose
H Ait-Oufella, A Tedgui, Z Mallat |
Revue Francophone des Laboratoires | 2007 |
Aspects immunologiques de l’athérome
É Groyer, G Caligiuri, J Laschet-Khallou, A Nicoletti |
La Presse Médicale | 2006 |
Thyroid epithelial cell hyperplasia in IFN-gamma deficient NOD.H-2h4 mice
S Yu, GC Sharp, H Braley-Mullen |
Clinical Immunology | 2005 |
Presence of IFN-γ Does Not Indicate Its Necessity for Induction of Coronary Arteritis in an Animal Model of Kawasaki Disease
WC Chan, TT Duong, RS Yeung |
Journal of immunology (Baltimore, Md. : 1950) | 2004 |
Stimulation of Primary Human Endothelial Cell Proliferation by IFN
D Gomez, NC Reich |
Journal of immunology (Baltimore, Md. : 1950) | 2003 |
Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis
N Gerdes, GK Sukhova, P Libby, RS Reynolds, JL Young, U Schönbeck |
Journal of Experimental Medicine | 2002 |
Prevention of Experimental Myointimal Hyperplasia by Immunomodulation
G Stansby, YC Chan, CS Berwanger, S Shurey, GA Rook, JL Stanford |
European Journal of Vascular and Endovascular Surgery | 2002 |
A Novel Role of Sp1 and Sp3 in the Interferon-γ-mediated Suppression of Macrophage Lipoprotein Lipase Gene Transcription
TR Hughes, TS Tengku-Muhammad, SA Irvine, DP Ramji |
The Journal of biological chemistry | 2002 |
Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis
GK Hansson, P Libby, U Schönbeck, ZQ Yan |
Circulation research | 2002 |
Evidence of Macrophage Foam Cell Formation by Very Low-Density Lipoprotein Receptor: Interferon-γ Inhibition of Very Low-Density Lipoprotein Receptor Expression and Foam Cell Formation in Macrophages
S Kosaka, S Takahashi, K Masamura, H Kanehara, J Sakai, Tohda, E Okada, K Oida, T Iwasaki, H Hattori, T Kodama, T Yamamoto, I Miyamori |
Circulation | 2001 |
Non-lipid-related effects of statins
S Bellosta, N Fed, F Bernini, R Paoletti, A Corsini |
Annals of Medicine | 2000 |
IL-18 binding protein increases spontaneous and IL-1-induced prostaglandin production via inhibition of IFN-gamma
LL Reznikov, SH Kim, JY Westcott, J Frishman, G Fantuzzi, D Novick, M Rubinstein, CA Dinarello |
Proceedings of the National Academy of Sciences | 2000 |
Interferon-gamma elicits arteriosclerosis in the absence of leukocytes
G Tellides, DA Tereb, NC Kirkiles-Smith, RW Kim, JH Wilson, JS Schechner, MI Lorber, JS Pober |
Nature | 2000 |
Interferon-gamma inhibits experimental renal fibrosis
SD Oldroyd, GL Thomas, G Gabbiani, AM el Nahas |
Kidney International | 1999 |
Tyrosine Kinase Regulatory Action on Ileal Muscarinic Effects of IFN-gamma
ME Sales, L Sterin-Borda, MM Bracco, ES Borda |
Journal of Interferon & Cytokine Research | 1999 |
Metal loproteases in remodeling of vascular extracellular matrix
ZS Galis |
Fibrinolysis and Proteolysis | 1999 |
Transcriptional suppression of rat angiotensin AT1a receptor gene expression by interferon-gamma in vascular smooth muscle cells
Y Ikeda, K Takeuchi, T Kato, Y Taniyama, K Sato, N Takahashi, A Sugawara, S Ito |
Biochemical and Biophysical Research Communications | 1999 |
Interferon gamma up-regulates a novel protein in vascular smooth muscle cells
E M Rzucidlo, W C Quist, A D Hamdan, F W LoGerfo |
Journal of Vascular Surgery | 1999 |
CD44, a Cell Surface Chondroitin Sulfate Proteoglycan, Mediates Binding of Interferon-γ and Some of Its Biological Effects on Human Vascular Smooth Muscle Cells
E Hurt-Camejo, B Rosengren, P Sartipy, K Elfsberg, G Camejo, L Svensson |
The Journal of biological chemistry | 1999 |
Interferon-γ-mediated Inhibition of Cyclin A Gene Transcription Is Independent of Individual cis -Acting Elements in the Cyclin A Promoter
NE Sibinga, H Wang, MA Perrella, WO Endege, C Patterson, M Yoshizumi, E Haber, ME Lee |
The Journal of biological chemistry | 1999 |
Evidence for Increased Collagenolysis by Interstitial Collagenases-1 and -3 in Vulnerable Human Atheromatous Plaques
GK Sukhova, U Schönbeck, E Rabkin, FJ Schoen, AR Poole, RC Billinghurst, P Libby |
Circulation | 1999 |
The 2–5 A system: Modulation of viral and cellular processes through acceleration of RNA degradation
MR Player, PF Torrence |
Pharmacology & Therapeutics | 1998 |
Pathomorphologie der koronaren Atherosklerose
C Ihling |
Herz | 1998 |
Class II cytokine receptor ligands inhibit human vascular smooth muscle proliferation
CH Selzman, BD Shames, TA Whitehill, AH Harken, RC McIntyre |
Surgery | 1998 |
Influence of FK506 on experimental atherosclerosis in cholesterol-fed rabbits
T Matsumoto, E Saito, H Watanabe, T Fujioka, T Yamada, Y Takahashi, T Ueno, T Tochihara, K Kanmatsuse |
Atherosclerosis | 1998 |
Atherosclerosis: cell biology and lipoproteins
KW Wahle |
Current Opinion in Lipidology | 1998 |
Proinflammatory cytokines differentially modulate their own expression in human intestinal mucosal mesenchymal cells
S A Strong, T T Pizarro, J S Klein, F Cominelli, C Fiocchi |
Gastroenterology | 1998 |
Regulation of CD44 Gene Expression by the Proinflammatory Cytokine Interleukin-1β in Vascular Smooth Muscle Cells
LC Foster, BM Arkonac, NE Sibinga, C Shi, MA Perrella, E Haber |
The Journal of biological chemistry | 1998 |
Differential Effects of IFN-β1b on the Proliferation of Human Vascular Smooth Muscle and Endothelial Cells
R Mintzer, E Croze, G Rubanyi, A Johns |
Journal of Interferon & Cytokine Research | 1998 |
New Insights into Plaque Stabilisation by Lipid Lowering:
P Libby, M Aikawa |
Drugs | 1998 |
IFN-gamma potentiates atherosclerosis in ApoE knock-out mice
S Gupta, AM Pablo, X Jiang, N Wang, AR Tall, C Schindler |
Journal of Clinical Investigation | 1997 |
Concurrence of Graves' Disease and Dysplastic Cerebral Blood Vessels of the Moyamoya Variety
BE Tendler, K Shoukri, C Malchoff, DO MacGILLIVRAY, R Duckrow, T Talmadge, GR Ramsby |
Thyroid | 1997 |
Pharmacologic control of smooth muscle cells in allografts
ML Foegh, PW Ramwell |
Transplant Immunology | 1997 |
Transfer and Expression of the Interferon Gamma Gene in Human Endothelial Cells Inhibits Vascular Smooth Muscle Cell Growth in Vitro
AT Stopeck, M Vahedian, SK Williams |
Cell Transplantation | 1997 |
Arterial Remodeling: A Critical Factor in Restenosis
A Lafont, EJ Topol |
1997 | |
The Role of Immune Mechanisms in Cardiovascular Disease
HP Schultheiss, P Schwimmbeck |
1997 | |
Modulation of intercellular communication between smooth muscle cells by growth factors and cytokines
A Mensink, A Brouwer, EH van Burg, S Geurts, WM Jongen, CM Lakemond, I Meijerman, TV der Wijk |
European Journal of Pharmacology | 1996 |
Involvement of Interleukin-6 and Interferon-α in the Poly(A).Poly(U)-Induced 2',5'-Ohgoadenylate Synthetase Activity in the Mouse Monocyte-Macrophage Cell Line, J774A1
JG Marin, JM Mencia-Huerta, P Braquet, PE Chabrier |
Journal of Interferon & Cytokine Research | 1996 |
Induction of ileum muscarinic cholinoceptor signal transduction pathways by rat interferon-gamma
L Sterin-Borda, E Borda, ME Sales, M Rodriguez, MM Bracco |
International Journal of Immunopharmacology | 1996 |
Nitric Oxide Attenuates Vascular Smooth Muscle Cell Activation by Interferon-: THE ROLE OF CONSTITUTIVE NF-κB ACTIVITY
WS Shin, YH Hong, HB Peng, RD Caterina, P Libby, JK Liao |
The Journal of biological chemistry | 1996 |
Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines
H Li, MW Freeman, P Libby |
Journal of Clinical Investigation | 1995 |
Involvement of nitric oxide in IFN-γ-mediated reduction of microvessel smooth muscle cell proliferation
CS Stein, Z Fabry, S Murphy, MN Hart |
Molecular Immunology | 1995 |
Cytokine therapy for arterial restenosis: inhibition of neointimal hyperplasia by gamma-interferon*1, *2
J Castronuovo |
Cardiovascular Surgery | 1995 |
Isolation of genes differentially expressed at the downstream anastomosis of prosthetic arterial grafts with use of mRNA differential displaydisplay*Winner of the 1994 Resident Prize Research Award
AD Hamdan, LP Aiello, WC Quist, CK Ozaki, MA Contreras, MD Phaneuf, C Ruiz, GL King, FW LoGerfo |
Journal of Vascular Surgery | 1995 |
Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases
ZS Galis, GK Sukhova, R Kranzhöfer, S Clark, P Libby |
Proceedings of the National Academy of Sciences | 1995 |
Molecular bases of the acute coronary syndromes
P Libby |
Circulation | 1995 |
Aspects of allograft rejection, I: Molecular pathology of acute and chronic rejection
P Häyry |
Transplantation Reviews | 1995 |
Interferon Gamma Binds to Extracellular Matrix Chondroitin-Sulfate Proteoglycans, Thus Enhancing Its Cellular Response
EH Camejo, B Rosengren, G Camejo, P Sartipy, G Fager, G Bondjers |
Arteriosclerosis, thrombosis, and vascular biology | 1995 |
Participation of T lymphocytes in atherogenesis: sequential and quantitative observation of aortic lesions of rats with diet-induced hypercholesterolaemia using en face double immunostaining
S Haraoka, T Shimokama, T Watanabe |
Virchows Archiv | 1995 |
Vascular Endothelium
MA Gimbrone, MI Cybulsky, N Kume, T Collins, N Resnick |
Annals of the New York Academy of Sciences | 1994 |
Introduction: Anti-inflammatory Treatment of Childhood Asthma: Cromoglycate and Nedocromil as Non-steroidal Alternatives?
JC de Jongste |
Mediators of Inflammation | 1994 |
Bidirectional Regulation of Smooth Muscle Cell Proliferation by IFN-^|^gamma;
K Shimokado, T Yokota, N Kato, C Kosaka, T Sasaguri, J Masuda, J Ogata, F Numano |
Journal of Atherosclerosis and Thrombosis | 1994 |
Human arterial smooth muscle cell strains derived from patients with moyamoya disease: changes in biological characteristics and proliferative response during cellular aging in vitro
N Fukai, M Aoyagi, M Yamamoto, H Sakamoto, K Ogami, Y Matsushima, K Yamamoto |
Mechanisms of Ageing and Development | 1994 |
Molecular and cellular concepts in atherosclerosis
M Sanders |
Pharmacology & Therapeutics | 1994 |
Graft Vessel Disease: The Impact of Immunosuppression and Possible Treatment Strategies
B Meiser, B Reichart |
Immunological Reviews | 1993 |
Supraumbilical Midabdominal Raphe, Sternal Atresia, and Hemangioma in an Infant: Response of Hemangioma to Laser and Interferon Alfa-2a
F Blei, SJ Orlow, RG Geronemus |
Pediatric Dermatology | 1993 |
Kinetics of125I-PDGF binding and down-regulation of PDGF receptor in arterial smooth muscle cells derived from patients with moyamoya disease
M Aoyagi, N Fukai, Y Matsushima, M Yamamoto, K Yamamoto |
Journal of Cellular Physiology | 1993 |
Interferon-γ inhibits DNA synthesis and insulin-like growth factor-II expression in human neuroblastoma cells
DM Martin, RO Carlson, EL Feldman |
Journal of Neuroscience Research | 1993 |
Chronic transplant rejection: Magnitude of the problem and pathogenetic mechanisms
LC Paul, H Benediktsson |
Transplantation Reviews | 1993 |
Chapter 5 Vascular lesion formation
P Libby, FJ Schoen |
Cardiovascular Pathology | 1993 |
Sustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injury
H Tanaka, GK Sukhova, SJ Swanson, SK Clinton, P Ganz, MI Cybulsky, P Libby |
Circulation | 1993 |
Diätetik und Arteriosklerose
H Heinle, H Schulte, HE Schaefer |
1993 | |
The HLA System in Clinical Transplantation
BG Solheim, S Ferrone, E Möller |
1993 | |
Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages
YJ Geng, GK Hansson |
Journal of Clinical Investigation | 1992 |
Functional significance of human vascular smooth muscle cell-derived interleukin 1 in paracrine and autocrine regulation pathways
H Loppnow, P Libby |
Experimental Cell Research | 1992 |
Mitogenic activity of interferon gamma on growth-arrested human vascular smooth muscle cells
T Yokota, K Shimokado, C Kosaka, T Sasaguri, J Masuda, J Ogata |
Arteriosclerosis Thrombosis and Vascular Biology | 1992 |
Differential control of mesangial cell proliferation by interferon-gamma
Y Kakizaki, N Kraft, RC Atkins |
Clinical & Experimental Immunology | 1991 |
Interleukin 1 regulates heparin-binding growth factor 2 gene expression in vascular smooth muscle cells
CG Gay, JA Winkles |
Proceedings of the National Academy of Sciences | 1991 |
International Review of Cytology
RA Miller |
International Review of Cytology | 1991 |
Treatment of childhood angiomatous diseases with recombinant interferon alfa-2a
CW White, SJ Wolf, DN Korones, HM Sondheimer, MF Tosi, A Yu |
The Journal of Pediatrics | 1991 |
Atherosclerosis as an immune disease?
G Clerc |
Medical Hypotheses | 1991 |
Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells
EP Amento, N Ehsani, H Palmer, P Libby |
Arteriosclerosis Thrombosis and Vascular Biology | 1991 |
Effects of transforming growth factor-beta 1 on human arterial smooth muscle cells in vitro
S Björkerud |
Arteriosclerosis Thrombosis and Vascular Biology | 1991 |
Chronic rejection in rat aortic allografts. An experimental model for transplant arteriosclerosis
A Mennander, S Tiisala, J Halttunen, S Yilmaz, T Paavonen, P Häyry |
Arteriosclerosis Thrombosis and Vascular Biology | 1991 |
Interferon-gamma inhibits arterial stenosis after injury
GK Hansson, J Holm |
Circulation | 1991 |
Atherosclerosis: Cellular and Molecular Interactions in the Artery Wall
AI Gotlieb, BL Langille, S Fedoroff |
Atherosclerosis | 1991 |
Differential control of mesangial cell proliferation by interferon-gamma.
Kakizaki Y, Kraft N, Atkins RC |
Clinical & Experimental Immunology | 1991 |
Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6
H Loppnow, P Libby |
Journal of Clinical Investigation | 1990 |
Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage colony-stimulating factor production by rheu
JM Alvaro-Gracia, NJ Zvaifler, GS Firestein |
Journal of Clinical Investigation | 1990 |
Effects of murine recombinant interferon-gamma on rat liver fat storing cell proliferation, cluster formation and proteoglycan synthesis
AM Gressner, M Althaus |
Biochemical Pharmacology | 1990 |
Encyclopedic Reference of Vascular Biology & Pathology
A Bikfalvi |
1990 |